Catalyzing Health.

Digitalis Commons develops biomedical technologies that serve the public interest.

Public interest biomedical technologies challenge the market-driven model of innovation by asking a different question: who benefits, and how broadly? This perspective highlights the gap between what markets prioritize (profit) and what society needs (health impact).

The Commons emphasizes developing technologies for underserved populations and neglected diseases, treating foundational scientific knowledge as a shared commons rather than private property, ensuring that publicly funded research delivers public benefit, and designing medical innovations with access and affordability as core principles rather than afterthoughts.

The Commons builds technologies that are:
01
Frontier-Advancing
A frontier-advancing solution has an outsized impact on health, but may struggle to find support from traditional funding sources.
02
Open-Access
An open-access solution produces public goods that have a disproportionate impact compared to privately-owned, proprietary solutions.
03
Scalable
A scalable solution requires institutional infrastructure, expertise, and capital.

Our People

Our people are our strongest asset—we pair deep in-house expertise with a broad network of external experts-in-residence (XIRs).

Notes

Accurately identifying and articulating the most pressing problems in health and healthcare is the first and most fundamental step in building frontier-advancing, scalable solutions.